Global Malaria Vaccine Market Set for Remarkable Growth in the Fight Against Malaria
31 oct. 2023 08h08 HE
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Malaria Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Global Therapeutics Vaccine Markets, Trends, Opportunities, and Forecast, 2018-2022 & 20232028F
27 oct. 2023 08h23 HE
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Therapeutics Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Next-Generation RNA Therapeutics and Vaccines Surge: Promising Modalities and Clinical Trials Fueling Growth in the RNA Market
12 oct. 2023 05h43 HE
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical...
Global Influenza Vaccine Market Research Report 2023: A $12.32 Billion Market by 2028 Driven by Increased Vaccine Awareness, Post COVID-19
05 oct. 2023 09h43 HE
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market: Analysis by Valency, By Vaccine Type, By Technology, By Age Group, By Route Of Administration, By Distribution...
High Prevalence of RSV in Infants and Elderly Pushes RSV Vaccine and Antibody Market Growth - Forecast to 2030
28 sept. 2023 04h58 HE
|
Research and Markets
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Forecast up to 2030" report has been added to ResearchAndMarkets.com's...
HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
26 sept. 2023 16h01 HE
|
HilleVax, Inc.
BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Global COVID-19 Vaccines Strategic Business Analysis Report 2023-2025: With New Strains Emerging at an Alarming Rate, Focus Shifts to Booster Doses & Vaccine Tweaking
25 sept. 2023 08h58 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Vaccines Market to...
HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
25 sept. 2023 07h00 HE
|
HilleVax, Inc.
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
HilleVax Announces Pricing of Public Offering of Common Stock
19 sept. 2023 20h05 HE
|
HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...
HilleVax Announces Proposed Public Offering of Common Stock
19 sept. 2023 16h09 HE
|
HilleVax, Inc.
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...